CCL2 and stroke disorder: Losartan at doses lower than 200 nM reduced the secretions of MCP-1 and TNF-α from Mo derived from healthy controls at 24 hours (p < 0.05); however, it did not have an effect on secretomes from stroke-Mo (Figures 1(i)–1(l)).